First Time Loading...

Idorsia Ltd
SIX:IDIA

Watchlist Manager
Idorsia Ltd Logo
Idorsia Ltd
SIX:IDIA
Watchlist
Price: 1.9 CHF 9.07% Market Closed
Updated: Apr 28, 2024

Intrinsic Value

IDIA's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Idorsia Ltd. operates as a biopharmaceutical firm which focuses on discovery, development and commercialization of innovative medicines for unmet medical needs. [ Read More ]

The intrinsic value of one IDIA stock under the Base Case scenario is 8.79 CHF. Compared to the current market price of 1.9 CHF, Idorsia Ltd is Undervalued by 78%.

Key Points:
IDIA Intrinsic Value
Base Case
8.79 CHF
Undervaluation 78%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Idorsia Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling IDIA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Idorsia Ltd

Provide an overview of the primary business activities
of Idorsia Ltd.

What unique competitive advantages
does Idorsia Ltd hold over its rivals?

What risks and challenges
does Idorsia Ltd face in the near future?

Summarize the latest earnings call
of Idorsia Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Idorsia Ltd.

Provide P/S
for Idorsia Ltd.

Provide P/E
for Idorsia Ltd.

Provide P/OCF
for Idorsia Ltd.

Provide P/FCFE
for Idorsia Ltd.

Provide P/B
for Idorsia Ltd.

Provide EV/S
for Idorsia Ltd.

Provide EV/GP
for Idorsia Ltd.

Provide EV/EBITDA
for Idorsia Ltd.

Provide EV/EBIT
for Idorsia Ltd.

Provide EV/OCF
for Idorsia Ltd.

Provide EV/FCFF
for Idorsia Ltd.

Provide EV/IC
for Idorsia Ltd.

Show me price targets
for Idorsia Ltd made by professional analysts.

What are the Revenue projections
for Idorsia Ltd?

How accurate were the past Revenue estimates
for Idorsia Ltd?

What are the Net Income projections
for Idorsia Ltd?

How accurate were the past Net Income estimates
for Idorsia Ltd?

What are the EPS projections
for Idorsia Ltd?

How accurate were the past EPS estimates
for Idorsia Ltd?

What are the EBIT projections
for Idorsia Ltd?

How accurate were the past EBIT estimates
for Idorsia Ltd?

Compare the revenue forecasts
for Idorsia Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Idorsia Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Idorsia Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Idorsia Ltd compared to its peers.

Compare the P/E ratios
of Idorsia Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Idorsia Ltd with its peers.

Analyze the financial leverage
of Idorsia Ltd compared to its main competitors.

Show all profitability ratios
for Idorsia Ltd.

Provide ROE
for Idorsia Ltd.

Provide ROA
for Idorsia Ltd.

Provide ROIC
for Idorsia Ltd.

Provide ROCE
for Idorsia Ltd.

Provide Gross Margin
for Idorsia Ltd.

Provide Operating Margin
for Idorsia Ltd.

Provide Net Margin
for Idorsia Ltd.

Provide FCF Margin
for Idorsia Ltd.

Show all solvency ratios
for Idorsia Ltd.

Provide D/E Ratio
for Idorsia Ltd.

Provide D/A Ratio
for Idorsia Ltd.

Provide Interest Coverage Ratio
for Idorsia Ltd.

Provide Altman Z-Score Ratio
for Idorsia Ltd.

Provide Quick Ratio
for Idorsia Ltd.

Provide Current Ratio
for Idorsia Ltd.

Provide Cash Ratio
for Idorsia Ltd.

What is the historical Revenue growth
over the last 5 years for Idorsia Ltd?

What is the historical Net Income growth
over the last 5 years for Idorsia Ltd?

What is the current Free Cash Flow
of Idorsia Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Idorsia Ltd.

Financials

Balance Sheet Decomposition
Idorsia Ltd

Current Assets 376.2m
Cash & Short-Term Investments 266.1m
Receivables 26.4m
Other Current Assets 83.7m
Non-Current Assets 276.9m
PP&E 212.3m
Intangibles 6.1m
Other Non-Current Assets 58.5m
Current Liabilities 311.1m
Accounts Payable 18.4m
Accrued Liabilities 65.2m
Other Current Liabilities 227.5m
Non-Current Liabilities 1.2B
Long-Term Debt 930.8m
Other Non-Current Liabilities 242.2m
Efficiency

Earnings Waterfall
Idorsia Ltd

Revenue
184.7m CHF
Cost of Revenue
-9.4m CHF
Gross Profit
175.3m CHF
Operating Expenses
-796m CHF
Operating Income
-620.7m CHF
Other Expenses
246.7m CHF
Net Income
-374.1m CHF

Free Cash Flow Analysis
Idorsia Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

IDIA Profitability Score
Profitability Due Diligence

Idorsia Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional ROE
Exceptional Revenue Growth Forecast
Positive Gross Profit
35/100
Profitability
Score

Idorsia Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

IDIA Solvency Score
Solvency Due Diligence

Idorsia Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Positive Net Debt
Long-Term Solvency
41/100
Solvency
Score

Idorsia Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IDIA Price Targets Summary
Idorsia Ltd

Wall Street analysts forecast IDIA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IDIA is 2.15 CHF with a low forecast of 1.01 CHF and a high forecast of 4.2 CHF.

Lowest
Price Target
1.01 CHF
47% Downside
Average
Price Target
2.15 CHF
13% Upside
Highest
Price Target
4.2 CHF
121% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

IDIA Price
Idorsia Ltd

1M 1M
-33%
6M 6M
+18%
1Y 1Y
-78%
3Y 3Y
-92%
5Y 5Y
-90%
10Y 10Y
-86%
Annual Price Range
1.9
52w Low
1.294
52w High
8.75
Price Metrics
Average Annual Return -3.21%
Standard Deviation of Annual Returns 39.35%
Max Drawdown -96%
Shares Statistics
Market Capitalization 339.3m CHF
Shares Outstanding 188 573 517
Percentage of Shares Shorted
N/A

IDIA Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Idorsia Ltd Logo
Idorsia Ltd

Country

Switzerland

Industry

Biotechnology

Market Cap

339.3m CHF

Dividend Yield

0%

Description

Idorsia Ltd. operates as a biopharmaceutical firm which focuses on discovery, development and commercialization of innovative medicines for unmet medical needs. The company is headquartered in Allschwil, Basel-Landschaft. The company went IPO on 2017-06-16. The firm will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The firm's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.

Contact

BASEL-LANDSCHAFT
Allschwil
Hegenheimermattweg 91
https://www.idorsia.com

IPO

2017-06-16

Employees

-

Officers

CEO & Executive Director
Mr. Jean-Paul Clozel M.D.
Executive VP & CFO
Mr. André C. Muller
Executive VP & Chief Scientific Officer
Dr. Martine Clozel
Senior VP and Head of Investor Relations & Corporate Communications
Mr. Andrew C. Weiss
Senior VP, Group General Counsel & Company Secretary
Mr. Julien Gander L.L.M.
Senior VP & Head of Global Human Resources
Mr. Alexander Khatuntsev
Show More
Executive VP & Chief Medical Officer
Dr. Guy Braunstein M.D.
Senior VP & Head of Technical Operations
Mr. Olivier Lambert
Senior VP & Head of Drug Discovery Biology
Mr. Markus A. Riederer
Senior VP & Head of Drug Discovery Chemistry
Mr. Christoph Boss
Show Less

See Also

Discover More
What is the Intrinsic Value of one IDIA stock?

The intrinsic value of one IDIA stock under the Base Case scenario is 8.79 CHF.

Is IDIA stock undervalued or overvalued?

Compared to the current market price of 1.9 CHF, Idorsia Ltd is Undervalued by 78%.